Key Details
Price
$0.50Annual ROE
-266.24%Beta
2.90Events Calendar
Next earnings date:
Mar 3, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
Mar 3, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 6, 25 William Blair
OutperformAug 27, 24 Citigroup
BuyAug 14, 24 Baird
NeutralMar 19, 24 JP Morgan
NeutralFeb 29, 24 Wedbush
OutperformFeb 29, 24 Truist Securities
BuyFeb 29, 24 Guggenheim
BuyFeb 29, 24 Baird
NeutralDec 4, 23 Citigroup
BuyAug 8, 23 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Mersana Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Mersana Therapeutics?
- Does Mersana Therapeutics pay dividends?
- What sector is Mersana Therapeutics in?
- What industry is Mersana Therapeutics in?
- What country is Mersana Therapeutics based in?
- When did Mersana Therapeutics go public?
- Is Mersana Therapeutics in the S&P 500?
- Is Mersana Therapeutics in the NASDAQ 100?
- Is Mersana Therapeutics in the Dow Jones?
- When was Mersana Therapeutics's last earnings report?
- When does Mersana Therapeutics report earnings?
- Should I buy Mersana Therapeutics stock now?
What is the ticker symbol for Mersana Therapeutics?
The ticker symbol for Mersana Therapeutics is NASDAQ:MRSN
Does Mersana Therapeutics pay dividends?
No, Mersana Therapeutics does not pay dividends
What sector is Mersana Therapeutics in?
Mersana Therapeutics is in the Healthcare sector
What industry is Mersana Therapeutics in?
Mersana Therapeutics is in the Biotechnology industry
What country is Mersana Therapeutics based in?
Mersana Therapeutics is headquartered in United States
When did Mersana Therapeutics go public?
Mersana Therapeutics's initial public offering (IPO) was on June 28, 2017
Is Mersana Therapeutics in the S&P 500?
No, Mersana Therapeutics is not included in the S&P 500 index
Is Mersana Therapeutics in the NASDAQ 100?
No, Mersana Therapeutics is not included in the NASDAQ 100 index
Is Mersana Therapeutics in the Dow Jones?
No, Mersana Therapeutics is not included in the Dow Jones index
When was Mersana Therapeutics's last earnings report?
Mersana Therapeutics's most recent earnings report was on Nov 13, 2024
When does Mersana Therapeutics report earnings?
The next expected earnings date for Mersana Therapeutics is Mar 3, 2025
Should I buy Mersana Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions